Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

SSSE:600645
16.20
CNY
-0.28
(-1.70%)
0.23EPS
79.88P/E
9.08BMarket Cap
Apr 23Next Earn
Vcanbio Cell & Gene Engineering Corp., Ltd. Class A
SSE:600645
(Shanghai Stock Exchange)

Recent

price

16.20

P/E

ratio

79.88

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.83
0.74
0.86
1
1.34
1.84
2.21
3.82
3.34
3.07
2.81
3.26
3.3
3.43
3.48
3.2
2.97
Revenue per Share
0.03
0.07
0.04
0.02
0.1
0.54
0.1
0.03
0.15
0.11
-0.27
0.33
0.24
0.23
0.22
0.25
0.24
Basic EPS, GAAP
0.53
0.29
0.04
0.11
0.45
-0.31
-0.33
0.05
- -
0.26
0.32
0.41
0.35
0.45
0.48
0.58
- -
Free Cash Flow per Basic Share
- -
- -
0.01
0.04
- -
0.03
0.02
0.03
0.03
0.03
0.01
- -
- -
- -
- -
- -
- -
Dividend per Share
0.41
0.48
0.45
1.44
2.93
4.02
4.11
7.14
6.29
7.17
7.3
7.4
7.6
7.87
7.68
7.92
8.16
Book Value per Share
0.31
0.4
0.24
1.2
1.1
2.26
2.26
3.44
3.47
4.72
5.43
5.58
5.8
6.06
5.84
6.08
6.35
Tangible Book Value per Share
322
335
347
361
355
386
379
346
395
452
470
471
471
463
456
455
463
Basic Weighted Avg Shares
268
247
300
361
477
709
838
1,321
1,321
1,387
1,319
1,535
1,555
1,590
1,585
1,455
1,375
Sales/Revenue/Turnover
17.57
17.37
4.84
1.25
10.97
15.4
14.15
8.22
8.38
14.41
9.29
12.46
10.92
11.32
12.84
13.51
14.03
Operating Margin (%)
28
25
33
33
34
45
56
101
102
96
103
125
138
144
142
139
- -
Depreciation Expense
8
23
14
7
35
208
38
10
59
50
-127
155
113
106
100
114
113
Net Income, GAAP
28.69
19.32
29.52
24.87
25.75
17.24
46.17
60.02
37.01
52.45
- -
32.18
31.26
25.67
34.27
40.65
42.88
Effective Tax Rate (%)
3.12
9.49
4.63
2
7.44
29.39
4.52
0.78
4.49
3.58
-9.62
10.12
7.27
6.7
6.33
7.82
8.18
Profit Margin (%)
64
71
-203
99
-251
-167
-351
-47
117
556
591
635
839
1,027
969
1,199
1,321
Working Capital
- -
- -
- -
- -
- -
38
79
141
119
35
79
48
102
86
68
47
44
LT Debt
244
269
282
660
1,156
1,682
1,752
2,965
2,981
3,461
3,521
3,533
3,654
3,799
3,659
3,755
3,854
Total Equity
12.42
17.79
7.43
0.57
4.65
14.46
2.41
0.86
2.04
1.54
- -
4.2
2.97
2.6
2.41
2.91
- -
Return on Invested Capital (%)
-4.39
-0.11
1.3
1.11
2.65
14.43
1.68
- -
1.88
1.49
- -
4.44
3.25
2.99
2.91
3.27
- -
Return on Capital (%)
6.43
16.24
9.19
2.23
4.62
16.11
2.41
0.48
2.14
1.62
-3.75
4.52
3.22
2.94
2.76
3.12
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
21
26
21
LT Borrowings
- -
- -
- -
LT Finance Leases
53
42
44
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
468
468
468
Market Capitalization
14,460
8,007
9,083

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,662
2,725
2,740
Cash, Cash Equivalents & STI
1,735
1,818
1,829
Accounts Receivable, Net
582
563
576
Inventories
232
236
239
Total Current Liabilities
1,413
1,430
1,418
Payables & Accruals
- -
- -
- -
ST Debt
21
26
21
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.85%
1.33%
2.62%
Free Cash Flow
588.1%
12.98%
21.21%
Net Income, GAAP
-30.21%
-49.55%
13.43%
Sales/Revenue/Turnover
8.73%
2.28%
-8.23%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
398
404
404
380
1,585
2025
351
366
- -
362
1,455
2026
317
342
354
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.1
0.11
-0.07
0.22
2025
0.06
0.07
- -
0.01
0.25
2026
0.05
0.08
0.1
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
I could not find direct search results specific to the latest major company changes for Vcanbio Cell & Gene Engineering Corp., Ltd (Ticker: 600645.SS). I will conduct a direct website fetch from the official company site to obtain comprehensive and accurate current information on their products, services, and recent major changes. Fetching from https://www.vcanbio.com now.